At present, we cannot exclude that the observed downregulation of TSP1 and ET1 in this cohort of premenopausal women may represent a transient compensatory mechanism to mitigate cardiovascular risk in the context of WHO Class II/III obesity [34]. The gene discussed is EDN1; the disease is Obesity.